"As always, we will continue to remain laser-focused on serving patients suffering from serious conditions like chronic pain, cancer, ALS and HIV/AIDS", the statement read, referring to conditions that patients are allowed to use medical marijuana to alleviate.
NY will allow ointments, lozenges and chewable tablets as part of its medical marijuana program while the state's training program for doctors will be cut in half, the Department of Health announced Thursday.
New Yorkers will have 30 days to comment on the proposed regulations when they are published later this month.
The DOH included in their announcement that the agency reserves the right to test and remove any products they deem are a public health hazard.
Along with the product changes, the new regulations also make changes for doctors and dispensaries.More news: Nadal marches into second round of Rogers Cup
More news: Mattis warns North Korea: aggression will mean the "end"
More news: Shares, dollar slip as US-North Korea tensions escalate
For one - companies that are registered to make and sell medical marijuana would be allowed to make more products.
The regulations will allow certified patients to visit dispensaries with individuals other than their designated caregivers, which was previously prohibited.
The DOH said they're also shortening the course for practitioners that is required to certify patients for medical marijuana.
The Health Department is also refining the training program for practitioners.
As of Aug 1 there were 25,736 patients certified for medical marijuana treatment. The five companies already operating were opposed to letting new players in, however, saying the market isn't big enough to divvy up further.